Neurelis Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Neurelis Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011852
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥28,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥56,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥84,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Neurelis Inc. (Neurelis) is a specialty pharmaceutical company, which develops medicines to target unmet medical need in epilepsy and acute anxiety episodes. The company’s product portfolio includes NRL-1 (intranasal diazepam), a proprietary formulation, for epilepsy in pediatric and adult patients who need to use diazepam sporadically to control bouts of acute repetitive seizures; NRL-2 (intranasal lorazepam), which gets absorbed rapidly through a nasal spray, providing swift clinical response. Neurelis obtained Orphan drug designation for NRL-1 from the FDA for the treatment of acute repetitive seizures. The company also licenses, develops, and commercializes product candidates for the broader central nervous system (CNS) market. Neurelis is headquartered in San Diego, California.

Neurelis Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Neurelis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Neurelis Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Neurelis Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Neurelis Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Neurelis Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Neurelis Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Neurelis Raises Funds through Series B Venture Financing 10
Neurelis Raises Funds in Series A Financing Round 11
Neurelis Secures US$1.08 Million In Venture Financing 12
Neurelis Inc – Key Competitors 13
Neurelis Inc – Key Employees 14
Neurelis Inc – Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Product Approvals 16
Jan 04, 2017: Neurelis Intranasal Diazepam Treatment For Epilepsy Granted Fast Track Designation By FDA 16
Jan 19, 2016: Neurelis Initiates Pivotal Clinical Program for NRL-1 in the Treatment of Acute Repetitive Seizures 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Neurelis Inc, Pharmaceuticals & Healthcare, Key Facts 2
Neurelis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Neurelis Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Neurelis Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Neurelis Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Neurelis Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Neurelis Raises Funds through Series B Venture Financing 10
Neurelis Raises Funds in Series A Financing Round 11
Neurelis Secures US$1.08 Million In Venture Financing 12
Neurelis Inc, Key Competitors 13
Neurelis Inc, Key Employees 14

★海外企業調査レポート[Neurelis Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Grand Gulf Energy Limited (GGE):企業の財務及び戦略的SWOT分析
    Summary Grand Gulf Energy Limited (Grand Gulf Energy) formerly Alto Energy International Limited is an oil and gas company that offers exploration services. The company’s activities include oil and gas exploration and production in productive US oil and gas basins. Its portfolio of active projects i …
  • Omega Diagnostics Group PLC (ODX):企業概要、財務及び戦略的SWOT分析
    Summary Omega Diagnostics Group PLC (Omega) is a biotechnology company. The company provides IVD products. It offers products in the areas of allergy, food intolerance, autoimmune disease and infectious disease. Omega also provides food intolerance and autoimmune tests for diseases such as anaemia, …
  • FlightSafety International, Inc.:企業の戦略・SWOT・財務分析
    SummaryFlightSafety International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the com …
  • Mackenzie Financial Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Mackenzie Financial Corporation …
  • INYPSA Informes y Proyectos S.A. (INY):企業概要、財務及び戦略的SWOT分析
    Summary INYPSA Informes y Proyectos S.A.(INYPSA) is an industrial and civil engineering consultancy company. The company offers service such as strategic planning and investment programming, preliminary feasibility and viability studies, permitting, project conception and design, contractor manageme …
  • ID Support Services Holdings, Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' ID Support Services Holdings, L …
  • Cameron International Corporation (CAM):企業のM&A・提携動向(石油・ガス分野)
    Summary Cameron International Corporation (Cameron) is an industrial equipment company that primarily caters to oil and gas industry. The company provides an array of products including flow equipment products, systems and services. It provides integrated solutions to the subsea, surface, drilling a …
  • Impax Laboratories, Inc.:企業のM&A・提携・投資分析
    Impax Laboratories, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Impax Laboratories, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Sunoco Logistics Partners, L.P.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Sunoco Logistics Partners, L.P. …
  • Da An Gene Co Ltd (002030):企業財務及び戦略的SWOT分析
    Summary Da An Gene Co Ltd (Daan Gene) is a medical device company that offers molecular diagnostic techniques. The company develops and produces in-vitro diagnostic products. It offers products such as molecular diagnostic products, repiratory infection, real-time PCR instrument, smart and easy solu …
  • Seiyu GK :企業の戦略・SWOT・財務分析
    SummarySeiyu GK - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings - Det …
  • Academia Sinica:企業のM&A・提携動向(医療分野)
    Summary Academia Sinica is a research institution that offers academic education services. The institute carries out academic research in the disciplines of mathematics and physical sciences, life sciences, and humanities and social sciences. It include research institutes and research centers. Acad …
  • ABC Supply Co. Inc.:企業のM&A・提携・投資分析
    ABC Supply Co. Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ABC Supply Co. Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Oliver Wyman Group:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Oliver Wyman Group Mergers and …
  • Tube Investments of India Limited (TUBEINVEST):企業の財務及び戦略的SWOT分析
    Summary Tube Investments of India Limited (TI), a subsidiary of Murugappa Group. is an engineering company that operates through business segments such as cycles and components, engineering and metal formed products. The company’s cycles and components division offers TI cycles which include BSA, He …
  • Neuronetics, Inc.:(医療機器分野)企業M&A及び提携動向
    Summary Neuronetics, Inc. (Neuronetics) is a medical device company. The company develops therapies for psychiatric and neurological disorders. It offers NeuroStar TMS Therapy System that is used to treat patients with depressive disorder. Neuronetics develops and commercializes non-invasive therapi …
  • Daishinku Corp. (6962):企業概要、財務及び戦略的SWOT分析
    Summary Daishinku Corp. (Daishinku) is an electronic component and equipment manufacturer. The company manufactures and sells crystal devices and resonators. Its products include crystal resonators, crystal oscillators, monolithic crystal filters, optical quartz products, and hermetic seal. Daishink …
  • DRDGOLD Limited:企業の戦略・SWOT・財務分析
    SummaryDRDGOLD Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Finding …
  • HupSteel Limited (BMH):企業財務及び戦略的SWOT分析
    Summary HupSteel Limited (HupSteel) formerly Hup Seng Huat Co. Ltd is an industrial goods company that offers hardware products. The company offers industrial hardware products for the oil and gas, chemical and petrochemical, energy, infrastructure, marine and other industries. Its products include …
  • Dragon Group International Limited (MT1):企業概要、財務及び戦略的SWOT分析
    Summary Dragon Group International Limited (DGI Group) is an investment holding company. The company offers vision systems, semiconductor assembly technologies and electro mechanical systems. Its services include distribution of electronic components and test consumables; supply of semiconductor equ …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆